Response to the letter to the editor: Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration

被引：0
|
作者：
Cheolmin Yun
Jaeryung Oh
机构：
[1] Korea University College of Medicine,Department of Ophthalmology
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2016年 / 254卷
关键词：
Optical Coherence Tomography; Diurnal Variation; Axial Length; Ranibizumab; Macular Degeneration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2067 / 2067
相关论文
共 50 条
  • [31] Aflibercept for Intravitreal Injection In Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    DRUGS & AGING, 2012, 29 (10) : 839 - 846
  • [32] Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab
    Freund, K. Bailey
    Hoang, Quan V.
    Saroj, Namrata
    Thompson, Desmond
    OPHTHALMOLOGY, 2015, 122 (09) : 1802 - 1810
  • [33] Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema
    Unlu, Cihan
    Erdogan, Gurkan
    Gunay, Betul Onal
    Kardes, Esra
    Akcay, Betul Ilkay Sezgin
    Ergin, Ahmet
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (01) : 147 - 158
  • [34] Determinants of Fixation in Eyes With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab
    Mathew, Raeba
    Pearce, Elizabeth
    Sivaprasad, Sobha
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (03) : 490 - 496
  • [35] Aflibercept for Intravitreal InjectionIn Neovascular Age-Related Macular Degeneration
    James E. Frampton
    Drugs & Aging, 2012, 29 : 839 - 846
  • [36] Subfoveal Choroidal Thickness after Ranibizumab Therapy for Neovascular Age-related Macular Degeneration: 12-Month Results
    Yamazaki, Taizo
    Koizumi, Hideki
    Yamagishi, Tetsuya
    Kinoshita, Shigeru
    OPHTHALMOLOGY, 2012, 119 (08) : 1621 - 1627
  • [37] Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema
    Cihan Ünlü
    Gurkan Erdogan
    Betul Onal Gunay
    Esra Kardes
    Betul Ilkay Sezgin Akcay
    Ahmet Ergin
    International Ophthalmology, 2017, 37 : 147 - 158
  • [38] Intravitreal brolucizumab in neovascular age-related macular degeneration with limited response to aflibercept
    Hatz, Katja B.
    Cedro, Luca
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [39] Response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory ranibizumab
    Ogata, N.
    Hasegawa, T.
    Yamashita, M.
    Okamoto, M.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [40] INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB A Treat-and-Extend Trial
    Hatz, Katja
    Prunte, Christian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1185 - 1192
12345